СОВРЕМЕННЫЕ НАПРАВЛЕНИЯ В ДИАГНОСТИКЕ МАЛЬТ-ЛИМФОМ ЖЕЛУДКА



Цитировать

Полный текст

Аннотация

В обзоре отражены современные данные по состоянию диагностики мальт-лимфом желудка и возможные новые направления для повышения уровня выявления патологических изменений. Обсуждается возможная взаимосвязь выявления мальт-лимфом с развитием и диагностикой опухолевых и неопухолевых процессов в желудке.

Полный текст

Доступ закрыт

Об авторах

В П КАЛИНОВСКИЙ

ФГУ «Научно-исследовательский институт онкологии им. проф. H. Н. Петрова», Санкт-Петербург

Санкт-Петербург, 189646, Песочный-2, ул. Ленинградская, 68

А Р ШУМАКОВ

ФГУ «Научно-исследовательский институт онкологии им. проф. H. Н. Петрова», Санкт-Петербург

Санкт-Петербург, 189646, Песочный-2, ул. Ленинградская, 68

Евгений Иванович ТКАЧЕНКО

ГОУ ВПО «Санкт-Петербургская государственная медицинская академия им. И. И. Мечникова»

Email: info@gastrofarm.ru

Ю А ЛИМАРЕВА

ГОУ ВПО «Санкт-Петербургская государственная медицинская академия им. И. И. Мечникова»

Список литературы

  1. Аруин Л.И., Капуллер Л.Л., Исаков В.А. Морфологическая диагностика болезней желудка и кишечника. М., 1998. 483 с.
  2. Гершанович М.Л., Калиновский В.П., Никитина М.В. и др. Новый метод лечения мальт-лимфом желудка // Вопр. онкол. 2010. Т. 25. С. 5-15.
  3. Калиновский В.П., Овсянников А.И., Успенская М.Н. и др. Разработка и применение метода количественного определения уреазы на планшетах у больных с хроническими заболеваниями желудка, ассоциированными с Helicobacter pylori // Гастроэнтерология Санкт-Петербурга. 2005. № 3-4. С. 50-53.
  4. Калиновский В.П., Щербаков А.М., Овсянников А.И. и др. Malt-лимфома желудка: биохимические, эндоскопические и морфологические критерии регрессии опухоли при комплексной химиотерапии: Пособие для врачей. СПб., 2011. 24 с.
  5. Новик A.A., Данилова И.А., Антонова И.В., Денисов Н.Л. Морфо-эпидемиологическое исследование MALT-лимфом желудка // Рос. журн. гастроэнтерол., гепатол., колопроктол. 1999. T. IX. № 5. Прил. 8. А126.
  6. Ashton-Key М., Biddolph S.C., Stein H. et al. Heterogeneity of bcl-2 expression in MALT lymphoma // Histopathology. 1995. Vol. 26. P. 75-78.
  7. Bacon C.M., Du M.Q., Dogan A. Mucosa-associated lymphoid tissue (MALT) lymphoma: a practical guide for pathologists// J. Clin. Pathol. 2007. Vol. 60. P. 361-372.
  8. Begum S., Sano T., Endo H. et al. Mucosal change of the stomach with low-grade mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: follow-up study of 48 cases // J. Med. Invest. 2000. Vol. 47. P. 36-46.
  9. Bende R.J., van Maldegem F., van Noesel C.J. Chronic inflammatory disease, lymphoid tissue neogenesis and extranodal marginal zone В-cell lymphomas // Haematologica. 2009. Vol. 94 (8). P. 1109-1123.
  10. Bishton М., Kencaly М., Johnstone R. et al. Epigenetic targets in hematological malignancies: combination therapies with HDACis and demethylating agents // Expert. Rev. Anticancer Ther. 2007. Vol. 7. P 1439- 1449.
  11. Brisslert M., Enarsson K., Lundin S. et al. Helicobacter pylori induce neutrophil transcndothelial migration: role of the bacterial HP-NAP // FEMS Microbiol. Lett. 2005. Vol. 249. P. 95-103.
  12. Cabral M.M., Mendes C.M., Castro L.P. et al. Apoptosis in Helicobacter pylori gastritis is related to cagA status // Helicobacter. 2006. Vol. 11. P. 469-476.
  13. Cohen S.M., Petryk M., Varma M. et al. Non-Hodgkin’s Lymphoma of Mucosa-Associated Lymphoid Tissue//Oncologist. 2006. Vol. 11. P. 1100-1117.
  14. Copie-Bergman C., Locher C., Levy M. et al. Metachronous gastric MALT lymphoma and early gastric cancer: is residual lymphoma a risk factor for the development of gastric carcinoma? //Ann. Oncol. 2005. Vol. 16. P. 1232-1236.
  15. D’Elios M.M., Amedei A., Cappon A. et al. The neutrophil-activating protein of Helicobacter pylori (HP-NAP) as an immune modulating agent // FEMS Immunol. Med. Microbiol. 2007. Vol. 50. P. 157-164.
  16. Du MQ. Molecular biology of gastric MALT lymphoma: application in clinical management // Hematology. 2002. Vol. 7. P. 339-344.
  17. Dundon W.G., Nishioka H., Polenghi A. et al. The neutrophil-activating protein of Helicobacter pylori // Int. J. Med. Microbiol. 2002. Vol. 291. P. 545-550.
  18. El-Zimaity H.M., El-Zaatari F.A., Dore M.P. et al. The differential diagnosis of early gastric mucosa-associated lymphoma: polymerase chain reaction and paraffin section immunophenotyping // Mod. Pathol. 1999. Vol. 12. P. 885-893.
  19. Ernst P. Review article: the role of inflammation in the pathogenesis of gastric cancer // Aliment Pharmacol. Ther. 1999. Suppl. 1. P. 13-18.
  20. Fischbach W., Goebeler M.E., Ruskone-Fourmestraux A. et al. Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy: experience from a large international series// Gut. 2007. Vol. 56. P. 1685-1687.
  21. Go J.H. Methylation analysis of cyclin-dependent kinase inhibitor genes in primary gastrointestinal lymphomas // Mod. Pathol. 2003. Vol. 16. P. 752-755.
  22. Go M.F., Chan K.Y., Versalovic J. et al. Cluster analysis of Helicobacter pylori genomic DNA fingerprints suggests gastroduodenal disease-specific associations // Scand. J. Gastroenterol. 1995. Vol. 7. P. 640-646.
  23. Hatz R.A., Meimarakis G., Lehn N. et al. Granulocyte activation by Helicobacter pylori // Eur. J. Med. Res. 1996. Vol. 1. P. 537-542.
  24. Herranz M., Esteller M. New therapeutic targets in cancer: the epigenetic connection // Clin. Transi. Oncol. 2006. Vol. 8. P. 242-249.
  25. Herranz M., Esteller M. DNA methylation and histone modifications in patients with cancer: potential prognostic and therapeutic targets // Methods Mol. Biol. 2007. Vol. 361. P. 25-62.
  26. Hosokawa Y. Anti-apoptotic action of API2-MALT1 fusion protein involved in t( 11; 18)(q21;q21 ) MALT lymphoma //Apoptosis. 2005. Vol. 10. P. 25-34.
  27. Hosokawa Y., Seto M. Nuclear factor kappaB activation and antiapoptosis in mucosa-associated lymphoid tissue lymphoma // Int. J. Hematol. 2004. Vol. 3. P. 215-223.
  28. Hosokawa Y., Suzuki H., Suzuki Y. et al. Antiapoptotic function of apoptosis inhibitor 2-MALT 1 fusion protein involved in t( 11; 18)(q21;q21 ) mucosa-associated lymphoid tissue lymphoma // Cancer Res. 2004. Vol. 64. P. 3452-3457.
  29. Huang Q., Ai L., Zhang Z.Y., Fan C.Y., Weiss L.M. Promoter hypermethylation and protein expression of the p16 gene: analysis of 43 cases of В-cell primary gastric lymphomas from China // Mod. Pathol. 2004. Vol. 17. P. 416-422.
  30. Isaacson P.G. Recent developments in our understanding of gastric lymphomas // Am. J. Surg. Pathol. 1996. Suppl. l.P. Sl-7.
  31. Isaacson P.G., Du M.Q. Gastric lymphomas: genetics and resistance to H. pylori eradication // Verh. Dtsch. Ges. Pathol. 2003. Vol. 87. P. 116-122.
  32. Isaacson P.G., Du M.Q. Gastrointestinal lymphoma: where morphology meets molecular biology // J. Pathol. 2005. Vol. 205. P. 255-274.
  33. Isaakson P., Wright D. Malygnant lymphoma of mucosa-associated lymphoid tissue: a distinctive В-cell lymphoma//Cancer. 1983. Vol. 52. P. 1410-1416.
  34. Konturek P.C., Konturek S.J., Brzozowski T. Helicobacter pylori infection in gastric carcinogenesis // J. Physiol. Pharmacol. 2009. Vol. 60. P. 3-21.
  35. Konturek P.C., Konturek S.J., Pierzchalski P. et al. Cancerogenesis in Helicobacter pylori infected stomachrole of growth factors, apoptosis and cyclooxygenases // Med. Sei. Monit. 2001. Vol. 7. P. 1092-1107.
  36. Leite K.R., Darini E., Canavez F.C. et al. Helicobacter pylori and cagA gene detected by polymerase chain reaction in gastric biopsies: correlation with histological findings, proliferation and apoptosis // Sao Paulo Med. J. 2005. Vol. 123. P. 113-118.
  37. Li Z., Wang H., Xue L. et al. Emu-BCL10 mice exhibit constitutive activation of both canonical and non-canonical NF-kappaB pathways generating marginal zone (MZ) В-cell expansion as a precursor to splenic MZ lymphoma // Blood. 2009. Vol. 114. P. 4158-4168.
  38. Lin W.C., Tsai H.F., Kuo S.H. et al. Translocation of Helicobacter pylori CagA into Human В lymphocytes,the origin of mucosa-associated lymphoid tissue lymphoma //Cancer Res. 2010. Vol. 70. P. 5740-5748.
  39. Lucas P.C., Yonczumi M., Inohara N. et al. Bel10 and MALT1. independent targets of chromosomal translocation in mall lymphoma, cooperate in a novel NF-kappa В signaling pathway // J. Biol. Client. 2001. Vol. 276. P. 19012-19019
  40. Martincz-Delgado B., Fernandez-Piqueras J., Garcia M.J. et al. Hypermethylation of a 5 CpG island of p16 is a frequent event in non-Hodgkin's lymphoma // Leukemia. 1997. Vol. 11. P. 425-428.
  41. Miehlke S., Genta R.M., Graham D.Y., Go M.F. Molecular relationships of Helicobacter pylori strains in a family with gastroduodenal disease //Am. J. Gastroenterol. 1999. Vol. 2. P. 364-368.
  42. Montalban C., Santon A., Redondo С. et al. Long-term persistence of molecular disease after histological remission in low-grade gastric MALT lymphoma treated with H. pylori eradication. Lack of association with translocation t( 11 ; 18): a 10-ycar updated follow-up of a prospective study // Ann. Oncol. 2005. Vol. 16 (9). P. 1539-1544.
  43. Morgner A., Bayerdörffer E., Neubauer A., Stolte M. Malignant tumors of the stomach. Gastric mucosa-associated lymphoid tissue lymphoma and Helicobacter pylori // Gastroenterol. Clin. North. Am. 2000. Vol. 29. P. 593-607.
  44. Muntean A.G., Hess J.L. Epigenetic dysregulation in cancer// Am. J. Pathol. 2009. Vol. 175. P. 1353- 1361.
  45. Nakagawa M., Seto M., Hosokawa Y. Molecular pathogenesis of MALT lymphoma: two signaling pathways underlying the antiapoptotic effect of API2-MALT1 fusion protein // Leukemia. 2006. Vol. 20. P. 929-936.
  46. Nakamura S., Aoyagi K., Iwanaga S. et al. Synchronous and metachronous primary gastric lymphoma and adenocarcinoma: a clinicopathological study of 12 patients // Cancer. 1997. Vol. 79. P. 1077-1085.
  47. Nakamura T., Inagaki H., Seto M. Nakamura S. Gastric low-grade В-cell MALT lymphoma: treatment, response, and genetic alteration 4 J. Gastroenterol. 2003. Vol. 10. P. 921-929.
  48. Nardone G., Staibano S., Rocco A. et al. Effect of Helicobacter pylori infection and its eradication on cell proliferation, DNA status, and oncogene expression in patients with chronic gastritis // Gut. 1999. Vol. 44. P. 789-799.
  49. Omonishi K., Yoshino T., Sakuma I. et al. bcl-6 protein is identified in high-grade but not low-grade mucosa-associated lymphoid tissue lymphomas of the stomach //ModPathol. 1998. Vol. 11. P. 181-185.
  50. Psyrri A., Papageorgiou S., Economopoulos T. Primary extranodal lymphomas of stomach: clinical presentation, diagnostic pitfalls and management // Ann. Oncol. 2008. Vol. 19. P. 1992-1999.
  51. Raderer M., Püspök A., Stummvoll G., Längle F., Chott A. Early cancer of the stomach arising after successful treatment of gastric MALT lymphoma in patients with autoimmune disease // Scand. J. Gastroenterol. 2003. Vol. 38. P. 294-297.
  52. Raderer M., Wöhrer S., Streubel B. et al. Assessment of disease dissemination in gastric compared with extragastric mucosa-associated lymphoid tissue lymphoma using extensive staging: a single-center experience //J.CIin. Oncol. 2006. Vol. 24. P. 3136-3141.
  53. Rokkas T., Ladas S., Liatsos C. et al. Relationship of Helicobacter pylori CagA status to gastric cell proliferation and apoptosis // Dig. Dis. Sci. 1999. Vol. 44. P. 487-493.
  54. Ruskoné-Fourmestraux A., Lavergne A., Aegerter P.H. et al. Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment // Gut. 2001. Vol. 48. P. 297-303.
  55. Siakantaris M.P., Pangalis G.A., Dimitriadou E. et al. Early-stage gastric MALT lymphoma: is it a truly localized disease? // Oncologist. 2009. Vol. 14. P. 148-154.
  56. Stathis A., Chini C., Bertoni F. et al. Long-term outcome following Helicobacter pylori eradication in a retrospective study of 105 patients with localized gastric marginal zone В-cell lymphoma of MALT type // Ann. Oncol. 2009. Vol. 20. P. 1086-1093.
  57. Sumida T., Kitadai Y., Hiyama T. et al. Antibodies to Helicobacter pylori and CagA protein arc associated with the response to antibacterial therapy in patients with H. pylori-positive API2-MALT1-negative gastric MALT lymphoma // Cancer Sei. 2009. Vol. 100. P. 1075-1081.
  58. Suzuki H., Saito Y., and Hibi T. Helicobacter pylori and Gastric Mucosa-associated Lymphoid Tissue (MALT) Lymphoma: Updated Review of Clinical Outcomes and the Molecular Pathogenesis // Gut and Liver. 2009. Vol. 3. P. 81-87.
  59. Thiberge J.M., Boursaux-Eudc C., Lehours P. et al. From array-based hybridization of Helicobacter pylori isolates to the complete genome sequence of an isolate associated with MALT lymphoma h BMC Genomics. 2010. Vol. 11. P. 368.
  60. Toyota M., Itoh F., Imai K. Can DNA methylation be a molecular marker for eradication of Helicobacter pylori in MALT lymphoma? 4 J. Gastroenterol. 2002. Vol. 37. P. 73-74.
  61. Umehara S., Higashi H., Ohnishi N., Asaka M., Hatakeyama M. Effects of Helicobacter pylori CagA protein on the growth and survival of В lymphocytes, the origin of MALT lymphoma // Oncogene. 2003. Vol. 22. P. 8337- 8342.
  62. Urakami Y., Sano T., Begum S. et al. Endoscopic characteristics of low-grade gastric mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori // J. Gastroenterol. Hepatol. 2000. Vol. 15. P. 113-119.
  63. Venizelos I., Tamiolakis D., Bolioti S., Nikolaidou S. Primary MALT lymphomas of the stomach: a pathological study of 18 cases // Rev. Esp. Enferm. Dig. 2007. Vol. 99. P 270-274.
  64. Vinatzer U., Gollinger M., Müllauer L., Mucosa-associated lymphoid tissue lymphoma: novel translocations including rearrangements of ODZ2, JMJD2C, and CNN3 // Clin. Cancer Res. 2008. Vol. 14. P 6426-6431.
  65. Walduck A.K., Weber M., Wunder С. et al. Identification of novel cyclooxygenase-2-dcpendent genes in Helicobacter pylori infection in vivo // Mol. Cancer. 2009. Vol. 8. P 22.
  66. Wiindisch T., Kim T.D., Thiede С. et al. Etiology and therapy of Helicobacter pylori-associated gastric lymphomas // Ann. Hematol. 2003. Vol. 82. P. 535-545.
  67. Xia H.H., Talley N.J. Apoptosis in gastric epithelium induced by Helicobacter pylori infection: implications in gastric carcinogenesis // Am. J. Gastroenterol. 2001. Vol. 96. P. 16-26.

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML
Скачать

© КАЛИНОВСКИЙ В.П., ШУМАКОВ А.Р., ТКАЧЕНКО Е.И., ЛИМАРЕВА Ю.А., 2011

Creative Commons License
Эта статья доступна по лицензии Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 74760 от 29.12.2018 г.


Данный сайт использует cookie-файлы

Продолжая использовать наш сайт, вы даете согласие на обработку файлов cookie, которые обеспечивают правильную работу сайта.

О куки-файлах